AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION.
暂无分享,去创建一个
A. Vinik | S. Tesfaye | Y. Handelsman | P. Camacho | J. Davidson | D. Ziegler | S. Reddy | Richard I Cook | H. Lando | Anne L Leddy | V. Spallone
[1] F. Cosentino,et al. The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2019, European heart journal.
[2] P. Novak. Electrochemical Skin Conductance Correlates with Skin Nerve Fiber Density , 2016, Front. Aging Neurosci..
[3] Barry I. Freedman,et al. Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function. , 2016, Diabetes technology & therapeutics.
[4] A. Vinik,et al. Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes , 2016, PloS one.
[5] B. S. Rasmussen,et al. Response to Comment on Rasmussen et al. A Randomized Controlled Trial Comparing Telemedical and Standard Outpatient Monitoring of Diabetic Foot Ulcers. Diabetes Care 2015;38:1723–1729 , 2015, Diabetes Care.
[6] I. Wilkinson,et al. SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy , 2015, PloS one.
[7] Donald W. Bowden,et al. Electrochemical Skin Conductance in Diabetic Kidney Disease , 2015, American Journal of Nephrology.
[8] M. Roden,et al. Effect of Low-Energy Diets Differing in Fiber, Red Meat, and Coffee Intake on Cardiac Autonomic Function in Obese Individuals With Type 2 Diabetes , 2015, Diabetes Care.
[9] A. Vinik,et al. The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention , 2015, Front. Endocrinol..
[10] Irl B Hirsch,et al. American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[11] R. D'Agostino,et al. Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality. , 2015, The Journal of clinical endocrinology and metabolism.
[12] A. Nicolucci,et al. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study , 2015, Acta Diabetologica.
[13] D. Matthews,et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2014, Diabetes Care.
[14] Sandra P. Reyna,et al. The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy. , 2014, Journal of diabetes and its complications.
[15] V. Convertino. Neurohumoral mechanisms associated with orthostasis: reaffirmation of the significant contribution of the heart rate response , 2014, Front. Physiol..
[16] Y. Park,et al. Cardiovascular Autonomic Dysfunction Predicts Severe Hypoglycemia in Patients With Type 2 Diabetes: A 10-Year Follow-up Study , 2013, Diabetes Care.
[17] A. Vinik,et al. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. , 2013, Diabetes technology & therapeutics.
[18] O. Melander,et al. Syndromes of orthostatic intolerance: a hidden danger , 2013, Journal of internal medicine.
[19] A. Vinik,et al. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease , 2013, Journal of diabetes investigation.
[20] R. Freeman,et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management , 2011, Diabetes/metabolism research and reviews.
[21] A. Vinik,et al. Autonomic imbalance: prophet of doom or scope for hope? , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[22] R. Hermida,et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes , 2011, Diabetes Care.
[23] A. Vinik. The approach to the management of the patient with neuropathic pain. , 2010, The Journal of clinical endocrinology and metabolism.
[24] A. Vinik,et al. Neuropathy: The Crystal Ball for Cardiovascular Disease? , 2010, Diabetes Care.
[25] M. Bulsara,et al. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. , 2010, The Journal of clinical endocrinology and metabolism.
[26] J. Dixon,et al. Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. , 2010, Pharmacology & therapeutics.
[27] J. Fleg,et al. Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial , 2010, Diabetes Care.
[28] Rodica Pop-Busui,et al. Cardiac Autonomic Neuropathy in Diabetes , 2010, Diabetes Care.
[29] J. Albers,et al. Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) , 2009, Circulation.
[30] P. Nestel,et al. Weight Loss May Reverse Blunted Sympathetic Neural Responsiveness to Glucose Ingestion in Obese Subjects With Metabolic Syndrome , 2009, Diabetes.
[31] A. Vinik,et al. Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.
[32] Mark E Molitch,et al. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. , 2006, Diabetes care.
[33] M. Lenhard,et al. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. , 2005, The Journal of clinical endocrinology and metabolism.
[34] W. Shoemaker,et al. Autonomic activity in trauma patients based on variability of heart rate and respiratory rate* , 2004, Critical care medicine.
[35] Braxton D Mitchell,et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. , 2003, Diabetes care.
[36] R. Freeman,et al. Diabetic autonomic neuropathy. , 2003, Diabetes care.
[37] A. Burger,et al. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. , 1999, The American journal of cardiology.
[38] F. Rubino,et al. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). , 1999, Journal of diabetes and its complications.
[39] H Wedel,et al. Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .
[40] O. Pedersen,et al. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study , 1999, The Lancet.
[41] F. Gries,et al. α-Lipoic Acid in the Treatment of Diabetic Peripheral and Cardiac Autonomic Neuropathy , 1997, Diabetes.
[42] D. Kendall,et al. Pancreas Transplantation Restores Epinephrine Response and Symptom Recognition During Hypoglycemia in Patients With Long-Standing Type I Diabetes and Autonomic Neuropathy , 1997, Diabetes.
[43] H Kaufmann,et al. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy , 1996, Clinical Autonomic Research.
[44] F. A. Gries,et al. The Epidemiology of Diabetic Neuropathy , 1993 .
[45] A. Hoes,et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.
[46] G. Arsos,et al. Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy. , 2006, Journal of diabetes and its complications.
[47] H. Boudoulas,et al. Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy. , 1998, Acta cardiologica.